Loss of the SdhB, but Not the SdhA, Subunit of Complex II Triggers Reactive Oxygen Species-Dependent Hypoxia-Inducible Factor Activation and Tumorigenesis
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 54 of the 54 references it cites were found in a registry or an index; 18 of the 61 sources its claims cite were checked for support.
Abstract
Mitochondrial complex II is a tumor suppressor comprised of four subunits (SdhA, SdhB, SdhC, and SdhD). Mutations in any of these should disrupt complex II enzymatic activity, yet defects in SdhA produce bioenergetic deficiency while defects in SdhB, SdhC, or SdhD induce tumor formation. The mechanisms underlying these differences are not known. We show that the inhibition of distal subunits of complex II, either pharmacologically or via RNA interference of SdhB, increases normoxic reactive oxygen species (ROS) production, increases hypoxia-inducible factor alpha (HIF-alpha) stabilization in an ROS-dependent manner, and increases growth rates in vitro and in vivo without affecting hypoxia-mediated activation of HIF-alpha. Proximal pharmacologic inhibition or RNA interference of complex II at SdhA, however, does not increase normoxic ROS production or HIF-alpha stabilization and results in decreased growth rates in vitro and in vivo. Furthermore, the enhanced growth rates resulting from SdhB suppression are inhibited by the suppression of HIF-1alpha and/or HIF-2alpha, indicating that the mechanism of SdhB-induced tumor formation relies upon ROS production and subsequent HIF-alpha activation. Therefore, differences in ROS production, HIF proliferation, and cell proliferation contribute to the differences in tumor phenotype in cells lacking SdhB as opposed to those lacking SdhA.
Overview
CoChat Summary
TL;DR
In multiple tumor cell lines and xenografts, suppressing the distal complex II subunit SdhB increased normoxic ROS and HIF-1α/HIF-2α stabilization, enhanced proliferation and tumor growth, whereas suppressing proximal SdhA did not increase ROS/HIF and reduced growth. The SdhB-driven growth phenotype required HIF-1α and/or HIF-2α, supporting an ROS-dependent pseudohypoxic mechanism for SdhB/C/D-linked tumorigenesis.
Key findings
- Pharmacologic inhibition at SdhD with TTFA (200 µM) increased normoxic HIF-1α, HRE-luciferase activity, and ROS (roGFP, DHE, Mito-SOX); SdhA inhibitors 3-NPA (100 µM) and MMA (1 mM) did not, and blocked TTFA-induced HIF-1α stabilization.
- Stable SdhB shRNA in 143B, A549, and Hep3B cells reduced complex II activity and increased normoxic HIF-1α/HIF-2α, VEGF mRNA, HRE-luciferase, and ROS; HIF stabilization was attenuated by ebselen (25 µM), Mito-Q (1 µM), or 3-NPA (100 µM).
- SdhA shRNA reduced complex II activity but did not significantly increase normoxic HIF-1α or ROS and decreased in vitro growth; SdhB shRNA increased in vitro growth and xenograft tumor growth/mass, while SdhA shRNA tumors grew more slowly than wild-type or SdhB shRNA tumors.
- In SdhB shRNA 143B cells, suppressing HIF-1α and/or HIF-2α significantly decreased in vitro growth, tumor growth, and tumor mass compared with dHIF control.
Methods
- Used Hep3B, A549, and 143B cells with stable shRNA against SdhB or SdhA, plus retroviral HIF-1α/HIF-2α shRNA in SdhB shRNA 143B cells; pharmacologic agents included TTFA, 3-NPA, MA, MMA, DMS, ebselen, Mito-Q, and TBAP.
- Measured complex II activity, HIF-1α/HIF-2α/VEGF by immunoblot, HRE-luciferase, ROS by roGFP, DHE, and Mito-SOX, in vitro growth, and nude mouse xenografts (1 × 10⁶ cells; monitored 25–35 days).
- Compared results to wild-type/mock controls; densitometry and P < 0.05 significance were used.
Limitations
- The paper states it cannot rule out that HIF accumulation with SdhD deficiency proceeds by a different mechanism than SdhB suppression, and that the results do not refute ROS production at SdhD via SdhB/C/D mutations.
- The paper notes the H₂O₂-mediated succinate accumulation model is not inconsistent, but required high H₂O₂ (100–500 µM) and it is unclear whether such levels occur in mitochondria.
- Evident from the text: findings rely on shRNA knockdown and pharmacologic inhibitors in three cell lines rather than patient-derived Sdh mutations, and no direct succinate measurements are reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
12 Valid · 0 Not valid · 22 Not checked · 84 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We previously reported that mitochondrial reactive oxygen species (ROS) signals arising from complex III trigger HIF-1 𝛂 stabilization during hypoxia (10, 21, 31).”
What the sources say
- Partly supportedcites [10] 10. Chandel, N. S., E. Maltepe, E. Goldwasser, C. E. Mathieu, M. C. Simon, and P. T. Schumacker. 1998. Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc. Natl. Acad. Sci. USA 95: 11715-11720. sourceExperimental — accuracy not yet measured
Our copy of Chandel et al. (1998) supports the mitochondrial/complex III part: 'Our results show that ROS generation at complex III is required for the induction of HIF-1 DNA binding activity during hypoxia' (Results and Discussion), and 'mitochondrial complex III acts as a principal site of ROS generation during hypoxia.' However, the endpoint the paper demonstrates is HIF-1 DNA-binding activity (gel shift) and downstream EPO/VEFG/glycolytic mRNA, not HIF-1α protein stabilization — the paper attributes stabilization to others ('hypoxic stabilization of the HIF-1 complex is related to the O2 concentration (31)', and Caro and Salceda (28) for lactacystin-induced stabilization). The claim's causal 'trigger' also outruns the paper's explicit hedge: 'Our model proposes only that ROS are required for the hypoxic activation of HIF-1, but it is not yet clear whether ROS are sufficient,' with ROS generators (antimycin, menadione) failing to elicit HIF-1 stabilization during normoxia. (LLM, conf=0.78)
- Not checked yetcites [21] 21. Guzy, R. D., B. Hoyos, E. Robin, H. Chen, L. Liu, K. D. Mansfield, M. C. Simon, U. Hammerling, and P. T. Schumacker. 2005. Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab. 1: 401-408. source
- Not checked yetcites [31] 31. Mansfield, K. D., R. D. Guzy, Y. Pan, R. M. Young, T. P. Cash, P. T. Schumacker, and M. C. Simon. 2005. Mitochondrial dysfunction resulting from loss of cytochrome c impairs cellular oxygen sensing and hypoxic HIF𝛂 activation. Cell Metab. 1: 393-399. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“An impairment in the normal removal of electrons from the flavin group in SdhA could promote superoxide generation through the autoxidation of the reduced flavin group by O 2 in the matrix (34, 38, 46, 51).”
What the sources say
- Partly supportedcites [34] 34. Messner, K. R., and J. A. Imlay. 2002. Mechanism of superoxide and hydrogen peroxide formation by fumarate reductase, succinate dehydrogenase, and aspartate oxidase. J. Biol. Chem. 277: 42563-42571. sourceExperimental — accuracy not yet measured
Our copy supports the mechanistic core: the flavin is the autoxidizing site in Sdh/Frd ('Flavin as the Site of Autoxidation'), Sdh 'makes only O2.-, and no H2O2, upon flavin autoxidation' (Succinate Dehydrogenase Makes Only Superoxide..., Fig. 9), and 'the relative preference of electrons to sit on the flavin is a major determinant of their tendency to autoxidize,' with Sdh's cofactor potentials 'arranged to withdraw electrons away from the flavin,' which 'may largely explain its comparatively low rate of autoxidation' — i.e. electrons retained on the flavin raise superoxide formation. Not supported by this paper: the specific counterfactual about an 'impairment in the normal removal of electrons from the flavin group in SdhA' (our copy names Sdh/FrdA mutants such as FrdA H44C and FrdB C62S, never an SdhA lesion), and the mitochondrial 'matrix' location — the work was done in E. coli inverted membrane vesicles with no reference to a matrix. (LLM, conf=0.75)
- Partly supportedcites [38] 38. Rustin, P., and A. Roetig. 2002. Inborn errors of complex II-unusual human mitochondrial diseases. Biochim. Biophys. Acta Bio-Energetics 1553: 117122. sourceExperimental — accuracy not yet measured
The Fig. 2 legend embedded in Section 3 ('Mutations in SDH B encoding the Ip subunit') does support the core idea for the SDH (Fp/Ip) subunits, including SdhA: 'some particular mutation could still favor an over-reduction of a given SDH component (e.g. flavin), resulting in superoxide production', and Section 5 adds that CII (SDH?) 'is a privileged location for superoxide production'. However, our copy nowhere states the specific mechanism the claim attributes — autoxidation of the reduced flavin by O2 — nor localises it to the matrix side (Fig. 1's legend only describes semi-quinone feeding electrons to the UQ pool). Searches for 'autoxidation', 'reduced flavin + O2' and 'matrix' returned no supporting passage, so the mechanistic detail likely rests on the sentence's other citations (34, 38, 46, 51) rather than this paper. (LLM, conf=0.72)
- Partly supportedcites [46] 46. Senoo-Matsuda, N., K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P. S. Hartman, and N. Ishii. 2001. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276: 41553-41558. sourceExperimental — accuracy not yet measured
Our copy supports the general premise — that impaired electron flow through complex II can raise superoxide production — with the DISCUSSION passage speculating that 'the complex II defect could affect electron flow such that there is a probable increase of electrons leaking directly from complex II to molecular oxygen,' and the Abstract identifying SDHA/Fp as the flavoprotein subunit. However, the paper never attributes superoxide generation to autoxidation of the reduced flavin group of SdhA by matrix O2; its specific proposed mechanism is premature release of semiquinone at the ubiquinone-binding site of Cyt-1/ceSDHC (residue 71, the mev-1 mutation), DISCUSSION. The flavin-autoxidation element of the claim is therefore absent from this source. (LLM, conf=0.72)
- Not checked yetcites [51] 51. Yankovskaya, V., R. Horsefield, S. Toernroth, C. Luna-Chavez, H. Miyoshi, C. Leger, B. Byrne, G. Cecchini, and S. Iwata. 2003. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science 299: 700-704. source
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Complex II oxidizes succinate to fumarate and transfers the electrons to ubiquinone through a sequence of steps involving a flavin moiety in SdhA, a set of iron-sulfur clusters in SdhB, a heme group in SdhC, and the ubiquinone binding site in SdhC and SdhD (Fig. 1) (1, 9).”
What the sources say
- Partly supportedcites [1] 1. Ackrell, B. A. C. 2000. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466: 1-5. sourceExperimental — accuracy not yet measured
The Introduction says complex II oxidizes succinate to fumarate and transfers electrons to ubiquinone; it also places FAD in the flavoprotein, three iron–sulfur clusters in the iron–sulfur subunit, and quinone-binding sites in the membrane anchors. Sections 3 and 4 describe electron transfer from FAD through the clusters to bound quinone, but do not place heme in that transfer sequence. Section 4 describes heme as coordinated by anchor helices and emphasizes its role in assembly, so the claim that electrons pass through a heme in SdhC is not supported. (LLM, conf=0.88)
- Not checked yetcites [9] 9. Cecchini, G. 2003. Function and structure of complex II of the respiratory chain. Annu. Rev. Biochem. 72: 77-109. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
What the sources say
- Could not verifycites [1] 1. Ackrell, B. A. C. 2000. Progress in understanding structure-function relationships in respiratory chain complex II. FEBS Lett. 466: 1-5. sourceExperimental — accuracy not yet measured
The Introduction discusses mutated respiratory-chain complex II in nematodes, and §2 (Flavoprotein subunit) describes a human mutation causing complex II deficiency. Neither passage addresses SDHB, SDHC, or SDHD mutations in familial paragangliomas or pheochromocytomas; searches for those tumors and for familial SDH mutations found no relevant passage. Page numbers were not available in our copy. (LLM, conf=0.75)
- Not checked yetcites [3] 3. Baysal, B. E., R. E. Ferrell, J. E. Willett-Brozick, E. C. Lawrence, D. Myssiorek, A. Bosch, A. van der Mey, P. E. Taschner, W. S. Rubinstein, E. N. Myers, C. W. Richard III, C. J. Cornelisse, P. Devilee, and B. Devlin. 2000. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science 287: 848-851. source
- Not checked yetcites [16] 16. Douwes Dekker, P. B. D., P. C. W. Hogendoorn, N. Kuipers-Dijkshoorn, F. A. Prins, S. G. Van Duinen, P. E. M. Taschner, A. G. L. Van der Mey, and C. J. Cornelisse. 2003. SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology. J. Pathol. 201: 480-486. source
- Supportedcites [19] 19. Gimenez-Roqueplo, A. P., J. Favier, P. Rustin, J. J. Mourad, P. F. Plouin, P. Corvol, A. Roetig, and X. Jeunemaitre. 2001. The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway. Am. J. Hum. Genet. 69: 1186-1197. source
The Discussion identifies SDHD, SDHC, and SDHB mutations as responsible for familial paraganglioma and describes its inheritance as usually autosomal dominant. The Introduction reports familial pheochromocytoma associated with SDHD and SDHB mutations; the paper's own family had an SDHD mutation and both tumor types. Page numbers were not provided in our copy. (LLM, conf=0.91)
- Partly supportedcites [33] 33. McWhinney, S. R., R. T. Pilarski, S. R. Forrester, M. C. Schneider, M. M. Sarquis, E. P. Dias, and C. Eng. 2004. Large germline deletions of mitochondrial complex II subunits SDHB and SDHD in hereditary paraganglioma. J. Clin. Endocrinol. Metab. 89: 5694-5699. sourceExperimental — accuracy not yet measured
The Abstract (page unavailable) says germline mutations in SDHB, SDHC, and SDHD cause hereditary pheochromocytoma/paraganglioma syndrome, supporting the link to familial tumors. Our copy explicitly calls SDHC-associated paraganglioma autosomal dominant in a reference title, but does not establish that inheritance pattern for all three genes; the Discussion (page unavailable) also notes maternal imprinting in SDHD-associated disease. (LLM, conf=0.82)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Other studies with diverse model systems also indicate that mutations in complex II can cause increases in ROS production (24, 25, 46, 51, 54).”
What the sources say
- Not checked yetcites [24] 24. Ishiguro, H., K. Yasuda, N. Ishii, K. Ihara, T. Ohkubo, M. Hiyoshi, K. Ono, N. Senoo-Matsuda, O. Shinohara, F. Yosshii, M. Murakami, P. S. Hartman, and M. Tsuda. 2001. Enhancement of oxidative damage to cultured cells and Caenorhabditis elegans by mitochondrial electron transport inhibitors. IUBMB Life 51: 263-268. source
- Not checked yetcites [25] 25. Ishii, N., M. Fujii, P. S. Hartman, M. Tsuda, K. Yasuda, N. Senoo-Matsuda, S. Yanase, D. Ayusawa, and K. Suzuki. 1998. A mutation in succinate dehydrogenase cytochrome b causes oxidative stress and ageing in nematodes. Nature 394: 694-697. source
- Supportedcites [46] 46. Senoo-Matsuda, N., K. Yasuda, M. Tsuda, T. Ohkubo, S. Yoshimura, H. Nakazawa, P. S. Hartman, and N. Ishii. 2001. A defect in the cytochrome b large subunit in complex II causes both superoxide anion overproduction and abnormal energy metabolism in Caenorhabditis elegans. J. Biol. Chem. 276: 41553-41558. source
Our copy directly demonstrates the attributed point: the Results section 'Production of Superoxide Anion from Mitochondria Is Elevated in mev-1 Mutants' reports ~2-fold higher superoxide production in mitochondria and SMP from mev-1 animals (which carry a missense mutation in Cyt-1/ceSDHC, the complex II cytochrome b large subunit) versus wild type, and the Discussion summary states mev-1 animals manifest 'superoxide anion overproduction from mitochondrial complex II itself... by the mutation in Cyt-1/ceSDHC subunit.' The hedged 'can cause' in the citing sentence matches the source's claim, and the paper's caveat that the effect is allele-specific (residue 71 missense; more severe mutations may not elevate superoxide) does not contradict a possibility-level statement. The one organism studied (C. elegans) is not overstated by the citing sentence, which pools this with other model systems. (LLM, conf=0.90)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
65 more claims · 2 with their cited sources checked
Create a free account to see all 118 claims and to verify the 43 references still open.
- Probably not a substantial claim. 15
- It may state two separate claims as one. 40
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This requires both succinate oxidation by the enzyme succinate dehydrogenase (SDH) and an increase in mitochondrial membrane potential.”
From Coupling Krebs cycle metabolites to signalling in immunity and cancer (2018) · cites this paper as [30]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“It has also been reported that defects in SDH B increase ROS production and that ROS enhance the stabilization of HIFα produced by succinate accumulation (Guzy et al., 2007), although the importance of ROS in this setting has been disputed (Lee et al., 2005; Selak et al., 2006).”
From Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. (2008) · cites this paper as Guzy et al., 2007
The cited source says what the claim attributes to it.
In the citing paper
“Accumulation of reactive oxygen species, an independent trigger for HIF stabilization, may contribute to this process in some cases of defective SDH or FH (Guzy et al., 2008; Sudarshan et al., 2009).”
From Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us? (2012) · cites this paper as Guzy et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ MATERIALS AND METHODS
“For dihydroethidium (DHE) and Mito-SOX experiments, cells were treated with the appropriate conditions for 5 to 6 h before the addition of DHE (10 𝛍 M) or Mito-SOX (1 𝛍 M) to the culture medium. Cells were incubated for an additional 1.5 h”
§ RESULTS
“After treatment for 5 h, DHE (1 𝛍 M) was added for an additional hour.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ RESULTS
“either polyclonal (SdhA clone 3) or monoclonal (SdhA clones 3C and 3L)”
§ RESULTS
“a monoclonal SdhA shRNA line (SdhA polyclonal line 3C)”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ MATERIALS AND METHODS
“Cells were incubated for an additional 1.5 h before being trypsinized and resuspended.”
§ RESULTS
“(H) Cells were treated with the indicated compounds for 5 h, after which Mito-SOX (1 𝛍 M) was added for an additional hour.”
Citations
Cites
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108 · cited 7×
“In a previous study, the suppression of SdhD expression led to an increase in HIF-1 stabilization, a response that was attributed to the inhibition of PHD by succinate that accumulated as a consequence of the impairment in complex II activity ( 43 ).”
BackgroundMethodInfluentialOxygen sensing by HIF hydroxylases
Schofield, C. J., & Ratcliffe, P. J. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1366 · Cited by 2,068 · cited 1×
“A similar model of substrate-mediated PHD inhibition has been described (23, 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
BackgroundChandel, N. S., McClintock, D. S., Feliciano, C. E., Wood, T. M., Melendez, J. A., Rodriguez, A. M., & Schumacker, P. T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001914200 · Cited by 2,000
Self-citationMitochondrial reactive oxygen species trigger hypoxia-induced transcription
Chandel, N. S., Maltepe, E., Goldwasser, E., Mathieu, C. E., Simon, M. C., & Schumacker, P. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11715 · Cited by 1,926 · cited 2×
“Previous studies have implicated complex III in the cellular O2-sensing pathway involved in the regulation of HIF- stability during hypoxia (10, 21).”
BackgroundSelf-citationMutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“However, mutations in subunit SdhB, SdhC, or SdhD are linked to tumorigenesis in the form of autosome-dominant familial paragangliomas and pheochromocytomas (1, 3, 16, 19, 33).”
BackgroundMitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing
Guzy, R. D., Hoyos, B., Robin, E., Chen, H., Liu, L., Mansfield, K. D., Simon, M. C., Hammerling, U., & Schumacker, P. T. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.05.001 · Cited by 1,545
Self-citationUbisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria
Turrens, J. F., Alexandre, A., & Lehninger, A. L. (1985) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(85)90293-0 · Cited by 1,214 · cited 1×
“Those interventions would be expected to increase cytosolic superoxide levels, because AA generates superoxide at the outer surface of the inner mitochondrial membrane (50) while p53 induces the expression of a variety of nonmitochondrial oxidase systems (53).”
BackgroundHanson, G. T., Aggeler, R., Oglesbee, D., Cannon, M., Capaldi, R. A., Tsien, R. Y., & Remington, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312846200 · Cited by 988 · cited 1×
“Using a novel, engineered, ratiometric fluorescent protein redox sensor (roGFP) (15, 22) expressed in cells by using a recombinant adenovirus, we find that the acute administration of TTFA significantly increases the rate of protein thiol oxidation compared to that induced by 3-NPA, MMA (Fig.”
BackgroundIsaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · cited 1×
“A similar model of substrate-mediated PHD inhibition has been described ( 23 , 37, 42) in which the loss of fumarate hydratase activity leads to the accumulation of fumarate, which also can inhibit PHD competitively.”
BackgroundArchitecture of succinate dehydrogenase and reactive oxygen species generation
Yankovskaya, V., Horsefield, R., Törnroth, S., Luna-Chavez, C., Miyoshi, H., Léger, C., Byrne, B., Cecchini, G., & Iwata, S. (2003) · Science · doi:10.1126/science.1079605 · Cited by 927 · cited 5×
“... II oxidizes succinate to fumarate and transfers the electrons to ubiquinone through a sequence of steps involving a flavin moiety in SdhA, a set of iron-sulfur clusters in SdhB, a heme group in SdhC, and the ubiquinone binding site in SdhC and SdhD (Fig. 1) (1, 9). When complex II is disrupted at SdhB, SdhC, or Sd…”
BackgroundInfluential
Cited by
Items 301–400 of 426
SNORA14A inhibits hepatoblastoma cell proliferation by regulating SDHB-mediated succinate metabolism
Zhu, J., Mao, S., Zhen, N., Zhu, G., Bian, Z., Xie, Y., Tang, X., Ding, M., Wu, H., Ma, J., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01325-0 · Cited by 16
“Loss of SDHB induces ROS production and subsequently stabilizes HIF-α, promoting osteosarcoma and lung cancer cell growth [43].”
BackgroundPhysiological and molecular predictors of cycling sprint performance
Galván-Álvarez, V., Gallego-Selles, Á., Martinez‐Canton, M., Pérez-Suárez, I., García-Gonzalez, E., Martín-Rincón, M., & Calbet, J. A. L. (2024) · Scandinavian Journal of Medicine and Science in Sports · doi:10.1111/sms.14545 · Cited by 16
“57 A similar mechanism may operate in human skeletal muscle, where a lower expression level of SDHB may facilitate ROS production already in basal conditions and even more during exercise.”
BackgroundLei, D., Hong, T., Li, L., Chen, L., Luo, X., Wu, Q., & Liu, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.12362 · Cited by 16
“In human cell lines, SDHB‐silencing, drug inhibition or RNA interference also eliminates the activity of complex II, and increases production of ROS and nuclear stability of HIF1α under normoxic conditions (37).”
BackgroundCabré, N., Luciano‐Mateo, F., Chapski, D. J., Baiges‐Gayà, G., Fernández‐Arroyo, S., Hernández‐Aguilera, A., Castañé, H., Rodríguez‐Tomàs, E., París, M., Sabench, F., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147830 · Cited by 15
“These differences were paralleled by changes in the mRNA transcription of succinate dehydrogenase B (SDHB), which is the subunit that participates in the electron transport chain [11].”
BackgroundComplex II assembly drives metabolic adaptation to OXPHOS dysfunction
Kugapreethan, R., Doomun, S. N. E., Sacharz, J., Frazier, A. E., Sharma, T., Low, Y. C., Nie, S., Leeming, M. G., Muellner-Wong, L., Last, K., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr6012 · Cited by 19
“In contrast, these cells produced significant SDHA active site–derived ROS from CII, another well-known HIF-1 α –stabilizing agent ( 50 , 55 ), which was lost in the absence of an ability to accumulate the SDHAF2-SDHA assembly (Fig.”
Jaitovich, A. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00292.2022 · Cited by 17
Sun, L., Kim, S. E., Mori, R., Miyaji, N., Nikawa, T., & Hirasaka, K. (2022) · Marine Drugs · doi:10.3390/md20110660 · Cited by 19
“Intriguing, the limitation of SDHB activity caused by augmented electron flux through complex II attracts HIF-1α activation in a ROS-dependent manner [52].”
BackgroundNeuroendocrine Tumors and Tumor Syndromes in Childhood
Gaal, J., & de Krijger, R. R. (2009) · Pediatric and Developmental Pathology · doi:10.2350/09-04-0635-cp.1 · Cited by 15
“Mutations in SDHA are also known to be involved in Leigh syndrome, a neurodegenerative disorder, in which both alleles are inactivated through mutations [82].”
BackgroundChang, L., Daly, C. L., Miller, D., Allen, P. D., Boyle, J. P., Hopkins, P. M., & Shaw, M. (2019) · British Journal of Anaesthesia · doi:10.1016/j.bja.2019.02.010 · Cited by 14
Patel, P. S., Castelow, C. D., Patel, D. S., Bhattacharya, S. K., Kuscu, C., Kuscu, C., Makowski, L., Eason, J. D., & Bajwa, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112993 · Cited by 15
“Even if SDH is mutated, cancer cells still undergo mitochondrial metabolism by producing ROS and metabolites for the Krebs Cycle [13].”
BackgroundTherapies targeting the signal pathways of pheochromocytoma and paraganglioma
Liu, Y., Liu, L., & Zhu, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s219056 · Cited by 14
“These, in turn, lead to increased activation of HIF-α.(46) The SDHx consists of four subunits: SDHA, SDHB, SDHC, and SDHD, and”
BackgroundInfluential15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma
Mannelli, M., Rapizzi, E., Fucci, R., Canu, L., Ercolino, T., Luconi, M., & Young, W. F. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0215 · Cited by 15
Parvanovova, P., Evinová, A., Grofik, M., Hnilicová, P., Tatarková, Z., & Koprušáková, M. T. (2024) · Biomedicines · doi:10.3390/biomedicines12061294 · Cited by 14
Hypoxia Induces Paclitaxel-Resistance through ROS Production
Oh, J., Ryu, Y., Lim, J., & Moon, E. (2010) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2010.18.2.145 · Cited by 13
“reports showed that physiological or pathophysiological hypoxia increased ROS production and HIF-1α stabilization (Simon, 2006; Guzy et al., 2008).”
BackgroundJiang, P., Wan, J. M., Cilieborg, M. S., Sit, W., & Sangild, P. T. (2013) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e318288cf71 · Cited by 13
“Among the identified proteins, succinate dehydrogenase is involved in oxidative phosphorylation (30) and electron transfer flavoproteinubiquinone oxidoreductase is involved in electron transfer in the mitochondrial respiratory chain (31), whereas fumarate hydratase functions in the citric acid cycle.”
BackgroundTargeting Mitochondrial Function for the Treatment of Breast Cancer
Deus, C. M., Coelho, A. R., Serafim, T. L., & Oliveira, P. J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.100 · Cited by 15
Protein S-glutathionylation and the regulation of cellular functions
Mailloux, R. J., Gill, R., & Young, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00013-4 · Cited by 22
Gao, J., Liu, H., Wang, X., Wang, L., Gu, J., Wang, Y., Yang, Z., Liu, Y., Yang, J., Cai, Z.-B., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1030644 · Cited by 15
Sun, L., Zhou, F., Shao, Y., Lv, Z., & Li, C. (2020) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2020.04.060 · Cited by 14
Metabolic Regulation of Hypoxia-Inducible Factors in Hypothalamus
Du, D., Zhang, Y., Zhu, C., Chen, H., & Sun, J. M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.650284 · Cited by 13
“Furthermore, only SDHB loss can trigger ROS formation and can stabilize HIF in mitochondrial complex II (52).”
BackgroundSerum Deprivation Enhances Apoptotic Cell Death by Increasing Mitochondrial Enzyme Activity
Moon, E. (2008) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2008.16.1.001 · Cited by 15
Hypoxia potentiates the cytotoxic effect of piperlongumine in pheochromocytoma models
Bullova, P., Cougnoux, A., Abunimer, L., Kopáček, J., Pastoreková, S., & Pacák, K. (2016) · Oncotarget · doi:10.18632/oncotarget.9643 · Cited by 13
“Partially because of pseudohypoxic conditions, high levels of ROS are present in PHEO/PGL, especially in SDHB-related tumors, most likely affecting tumorigenesis, as high ROS levels influence HIF signaling [19].”
BackgroundBalnis, J., Tufts, A., Jackson, E. L., Drake, L. A., Singer, D. V., Lacomis, D., Lee, C. G., Elias, J. A., Doles, J. D., Maher, L. J., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado8549 · Cited by 14
“Previous evidence indicates that dysfunction of SDH subunits located at the ubiquinol binding site (as in subunit C) leads to increased ROS formation, unlike dysfunction in SDHA ( 65 ).”
BackgroundLi, H., Hu, B., Luo, Q., Hu, S., Luo, Y., Zhao, B., Gan, Y., Li, Y., Shi, M., Nie, Q., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01337 · Cited by 11
Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism
Tevosian, S. G., & Ghayee, H. K. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01991 · Cited by 12
Mitochondrial ROS production during ischemia-reperfusion injury
Prag, H. A., Kula‐Alwar, D., Beach, T. E., Gruszczyk, A. V., Burger, N., & Murphy, M. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-818606-0.00026-2 · Cited by 15
Gregorio, E. D., Miolo, G., Saorin, A., Steffan, A., & Corona, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115574 · Cited by 12
“The SDH genes (SDHA, SDHB, SDHC, SDHD) encode the subunits of the succinate dehydrogenase tetrameric complex also known as mitochondrial complex II, which is involved in the TCA cycle as well as in the aerobic electron transport chain (ETC) [33] (Figure 1).”
BackgroundAltered Dynamics of Intestinal Cell Maturation in Apc1638N/+ Mice
Wang, D., Pezo, R. C., Corner, G. A., Sison, C. P., LESSER, M. L., Shenoy, S. M., Mariadason, J. M., Singer, R. H., & Augenlicht, L. H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4593 · Cited by 12
“Oncogenic mutations in enzymes of the TCA cycle can generate a pseudohypoxic response and a shift of metabolism toward glycolysis, characterized by increased expression of Hif1α, a transcription factor regulated posttranslationally that coordinates hypoxic response (36, 37).”
Pitfalls of Mitochondrial Redox Signaling Research
Ježek, P. (2023) · Antioxidants · doi:10.3390/antiox12091696 · Cited by 11
Hypoxic Signaling Pathways in Carotid Body Tumors
Cao, K., Yuan, W., Hou, C., Wang, Z., Yu, J., & Wang, T. (2024) · Cancers · doi:10.3390/cancers16030584 · Cited by 13
“The central convergence point of oxygen-sensing pathways is represented by the hypoxia-inducible factors, HIF1 α and HIF2 α , which are encoded by the genes HIF1A and EPAS1 , respectively, and their expressions in the carotid body are shown in Table 2 [51].”
BackgroundKrebs Cycle Rewired: Driver of Atherosclerosis Progression?
Liang, Y., Chen, Y., Lü, L., Zhang, S., Xiao, J., & Wei, D. (2021) · Current Medicinal Chemistry · doi:10.2174/0929867328666210806105246 · Cited by 12
Celada, L., Cubiella, T., San‐Juan‐Guardado, J., Martínez, A. S. J., Valdés, N., Jiménez‐Fonseca, P., Díaz, I., Enguita, J. M., Astudillo, A., Álvarez-González, E., et al. (2022) · Cancers · doi:10.3390/cancers14122986 · Cited by 12
Lee, S., Needleman, L., Park, J. R., Schugar, R. C., Guo, Q., Ford, J. M., & Annes, J. P. (2025) · Journal of Clinical Investigation · doi:10.1172/jci198165 · Cited by 16
“However, our study is, to our knowledge, the first to functionally findings raise the possibility that the pathogenicity of SDHA/B PMD alleles is not solely attributable to impaired succinate oxidation but reflects a distinct pathogenic mechanism, such as altered ROS generation (58–60).”
MUC1 triggers lineage plasticity of Her2 positive mammary tumors
Pang, Z., Dong, X., Deng, H., Wang, C., Liao, X., Liao, C., Liao, Y., Tian, W., Cheng, J., Chen, G., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02320-y · Cited by 9
“SDHB and SDHD are involved in the SDH complex (SDHA, SDHB, SDHC, and SDHD), and a deficiency of this enzyme is known to activate tumor formation through dysregulation of reactive oxygen speciesdependent hypoxia-inducible factor (HIF) activity [43, 44].”
BackgroundLiu, H., Fu, G., Li, W., Liu, B., Ji, X., Zhang, S., & Qiao, K. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-28893-z · Cited by 9
Sp, N., Kang, D., Kim, D., Lee, H. G., Park, Y., Kim, I., Lee, H., Cho, B., Jang, K., & Yang, Y. M. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.8196 · Cited by 9
“In a previous study that implemented knockdown of SDH complexes, SDHB knockdown resulted in increased cytosolic oxidative stress, whereas SDHA knockdown did not, indicating that SDHA is a stable reference gene under stress conditions (23).”
González, C., Nurse, C. A., & Peers, C. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-2259-2 · Cited by 13
Yamanaka, M., Shiga, K., Fujiwara, S., Mizuguchi, Y., Yasuda, S., Ishizawa, K., Saiki, Y., Higashi, K., Ogawa, T., Kimura, N., et al. (2018) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.245.99 · Cited by 8
Turano, M., Vicidomini, R., Cammarota, F., D’Agostino, V., Duraturo, F., Izzo, P., & Rosa, M. D. (2023) · Biomedicines · doi:10.3390/biomedicines11051428 · Cited by 9
Kent, J. D., Klug, L. R., & Heinrich, M. C. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-1601 · Cited by 8
Murray-Cors, S., Owens, M., Liew, Y.-T., Day, M., Cairns, W., & Prokop, A. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1631752 · Cited by 9
Hypoxia and Reactive Oxygen Species
Görlach, A. (2013) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9167-5_4 · Cited by 8
Paddenberg, R., Faulhammer, P., Goldenberg, A., Gries, B., Heinl, J., & Kummer, W. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-90-481-2259-2_41 · Cited by 8
“Instead, they may result from modulation of several, independently involved mitochondrial protein complexes such as ROSproducing complex II (Paddenberg et al. 2006; Guzy et al. 2008 ) and ANT-regulated mitochondrial permeability transition pore (Leung and Halestrap 2008).”
BackgroundYang, Y., Jiao, Y., & Mohammadi, M. R. (2023) · Cellular Molecular and Biomedical Reports · doi:10.55705/cmbr.2023.378480.1091 · Cited by 7
“Studies have shown that succinate dehydrogenase (SDH) mutations are present in most tumors, and the accumulation of succinate and succinylation of protein lysine caused by SDH mutations may be important factors in promoting tumor development [35].”
BackgroundSarin, H. V., Pirinen, E., Pietiläinen, K. H., Isola, V., Häkkinen, K., Perola, M., & Hulmi, J. J. (2021) · The FASEB Journal · doi:10.1096/fj.202002029r · Cited by 7
Lee, D., Park, J.-S., Kim, Y., & Lee, H.-S. (2014) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-014-5823-3 · Cited by 8
“In humans, mutations in succinate dehydrogenase subunits B or C result in increased superoxide radicals and oxidative stress (Slane et al. 2006; Guzy et al. 2008).”
BackgroundLiu, H., Das, P. P., Zhang, J., Yu, L., Wang, M., Lin, Q., Zhou, Y., Xu, Q., & Wong, S. (2021) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104314 · Cited by 7
Analysis of succinate dehydrogenase subunit B gene alterations in gastric cancers
Cao, Z., Song, J. H., Kang, Y. W., Yoon, J., Nam, S. W., Lee, J. Y., & Park, W. S. (2010) · Pathology International · doi:10.1111/j.1440-1827.2010.02558.x · Cited by 8
Targeting Immune Cell Metabolism: A Promising Therapeutic Approach for Cardiovascular Disease
Xia, D., Zheng, Q., Liu, Y., Wang, L., & Wei, D. (2025) · Immunology · doi:10.1111/imm.13913 · Cited by 9
“It increases the stability of HIF-α in a ROS-dependent manner [83].”
InfluentialOxidative stress and metabolic dysfunction in oral lichen planus pathogenesis
Song, H.-J., Kang, K.-H., Byun, J., & Kim, D. H. (2026) · Animal Cells and Systems · doi:10.1080/19768354.2026.2648907 · Cited by 6
“Loss or mutation of SDHB disrupts electron flow, leading to succinate accumulation, impaired oxidative phosphorylation, and mitochondrial ROS production (Guzy et al. 2008).”
Genetic diagnosis in acromegaly and gigantism: From research to clinical practice
Ramírez‐Rentería, C., & Hernández-Ramírez, L. C. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101892 · Cited by 8
An Update on the Genetic Drivers of Corticotroph Tumorigenesis
Hernández-Ramírez, L. C., Perez‐Rivas, L. G., Theodoropoulou, M., & Korbonits, M. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2337-2265 · Cited by 7
Microarray analysis of differential utilization of plant-based diets by rainbow trout
Overturf, K., Vallejo, R. L., Palti, Y., Barrows, F. T., & Parsons, J. E. (2011) · Aquaculture International · doi:10.1007/s10499-011-9490-4 · Cited by 10
“The expression of SDHB genes also negatively regulates cell growth (Guzy et al. 2008).”
BackgroundThe Role of Mitochondrial Oxidative Stress and ATP Depletion in the Pathology of Manganese Toxicity
Gunter, T. E., Gavin, C. E., & Gunter, K. K. (2012) · Springer eBooks · doi:10.1007/978-1-4419-9663-3_29 · Cited by 9
Rahn, S., Barbosa, P. V., Möller, J. L., Ammar, N., Demetrowitsch, T. J., Helm, O., Wesch, D., Sipos, B., Röcken, C., Schwarz, K., et al. (2019) · Cancers · doi:10.3390/cancers12010042 · Cited by 8
“provided evidence that SDHB does not exert its tumor suppressive properties via bioenergetic regulation [35].”
BackgroundGenetic approaches to understand cellular responses to oxygen availability
Ortmann, B. M., & Nathan, J. A. (2021) · FEBS Journal · doi:10.1111/febs.16072 · Cited by 7
WITHDRAWN: Glutaminolysis-induced mTORC1 activation drives non-alcoholic steatohepatitis progression
Cabré, N., Luciano‐Mateo, F., Chapski, D. J., Baiges‐Gayà, G., Fernández‐Arroyo, S., Hernández‐Aguilera, A., Castañé, H., Rodríguez‐Tomàs, E., París, M., Sabench, F., et al. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.04.037 · Cited by 6
RetractedPetrák, J., Tevosian, S. G., Richter, S., & Ghayee, H. K. (2024) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2024.101935 · Cited by 5
Li, H., Li, X., Wang, Y., Han, W., Li, H., & Zhang, Q. (2024) · Inflammation · doi:10.1007/s10753-024-01966-y · Cited by 7
“Studies have shown that oxidative stress can inhibit the hydroxylation of the substrate HIF1α by PHD through multiple mechanisms, including the direct inhibition of the PHD enzyme activity [38], inducing the decarboxylation of α-ketoglutarate (α-KG) [39], and oxidizing iron (Fe 2+ ) to Fe 3+ [40].”
Schumacker, P. T. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0200ed · Cited by 5
“in ROS generation from the SDHA subunit (7).”
BackgroundSelf-citationLiao, Z.-Q., Lv, Y., Kang, M., Ji, Y., Liu, Y., Wang, L., Tang, J., Deng, Z., Yi, Y., & Tang, Q. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23812 · Cited by 7
Zhang, W., Zhao, Y., He, Q., & Lang, R. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1211126 · Cited by 6
“According to experimental data, SDH mutations can lead to succinate accumulation and subsequent stabilization of hypoxia-inducible factor-1 alpha (HIF-1a), thereby promoting tumor growth (11) (Figure 1).”
BackgroundTargeting mitochondrial metabolites and nucleic acids as an anti-inflammatory strategy
Min, Y., & O'Neill, L. A. J. (2023) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2023.1294454 · Cited by 8
Pseudohypoxia, Mitochondrial Mutations, the Warburg Effect, and Cancer.
Sanders, E. (2012) · Cited by 5
The effects of phenolic microbial metabolites on the activities of mitochondrial enzymes
Fedotcheva, N. I., Litvinova, E. G., Osipov, A. A., Olenin, A. Y., Moroz, V. V., & Nv, B. (2015) · BIOPHYSICS · doi:10.1134/s0006350915060068 · Cited by 4
Role of Succinate Dehydrogenase in Cellular Respiration
Viswalingam, V., & Kumar, D. (2025) · Springer eBooks · doi:10.1007/978-981-96-6831-1_3 · Cited by 3
Complementary Muscle Metabolomics and Proteomics of Muscle in Cows With Post-Calving Ketosis
Tang, T., Zhou, J., Shao, J., Wang, M., Xia, S., Sun, W., Jia, X., Wang, J., & Lai, S. (2025) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.70214 · Cited by 3
“As another subunit of SDH, the main role of SDHB is to participate in electron transfer, passing electrons from SDHA to coenzyme Q (CoQ), thus entering the respiratory chain [49].”
Inflammation-induced adrenal dysfunction
Chortis, V., & Breault, D. T. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00896-3 · Cited by 3
Metabolic Pathways of Eukaryotes and Connection to Cell Mechanics
Mierke, C. T. (2020) · Biological and medical physics, biomedical engineering · doi:10.1007/978-3-030-58532-7_17 · Cited by 2
Regulating Mitochondrial Respiration in Cancer
Serafim, T. L., & Oliveira, P. J. (2014) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-1-4614-9545-1_3 · Cited by 3
“Complex II has also been shown to be another source, possibly at the FAD coenzyme present in SDHA [145] or in a mutated SDHC subunit [281].”
BackgroundIn Silico Modeling of Angiogenesis at Multiple Scales: From Nanoscale to Organ System
Qutub, A. A., Gabhann, F. M., Karagiannis, E. D., & Popel, A. S. (2010) · Wiley eBooks · doi:10.1002/9780470579831.ch10 · Cited by 3
Sun, Z., Sun, L., Hu, H., Ren, Y., Zhu, W., Wang, X., Gu, W., Huang, S., Zhong, D., Sun, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-65790-0 · Cited by 2
Mitochondrial Respiratory Chain Complex II
Ganesh, J., Wong, L. C., & Gorman, E. B. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3722-2_13 · Cited by 4
Microenvironmental Regulation of Innate Immune Cell Function
Watts, E., Ryan, E. M., Walmsley, S. R., & Whyte, M. K. B. (2017) · Wiley-VCH eBooks · doi:10.1002/9783527692156.ch36 · Cited by 3
Manakov, D., Kolář, D., Zurmanova, J. M., Pravenec, M., & Novotný, J. (2018) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-018-0641-1 · Cited by 2
Paranagama, M. P., & Kita, K. (2018) · InTech eBooks · doi:10.5772/intechopen.71638 · Cited by 2
“[25] in intact cells of the hepatoma cell line Hep3B by inhibiting the complex II activity by the Q site inhibitor theonyl trifluoroacetone (TTFA) and by RNA interference of Ip subunit.”
Loss of SDHB reprograms energy metabolisms and inhibits high fat diet induced metabolic syndromesPreprint
Mu, C., Ma, B., Zhang, C., Geng, G., Zhang, X., Chen, L., Wang, M., Li, J., Zhao, T., Cheng, H., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/259226 · Cited by 3
“Pathways including the ROS-HIF1/2A pathway [25] and the”
BackgroundTang, M., Yang, M., Feng, R., Lin, J., Chen, X., Zou, H., Chen, C., Song, L., & Li, J. (. (2026) · Targetome · doi:10.48130/targetome-0026-0007 · Cited by 2
Guo, Q., Lee, S., Armstrong, N., Lim, B., Schugar, R. C., Tomz, D., Xu, H., Zhen, A., Needleman, L., Kebebew, E., et al. (2026) · Endocrine Related Cancer · doi:10.1530/erc-25-0397 · Cited by 2
Can Superoxide Anions Predict the Malignant Potential of Carotid body Tumor? - A Pilot Study
Kajal, S., Kairo, A. K., Quadri, J. A., Sarwar, S., Ahmed, A., Ahmad, S., Kakkar, A., Shariff, A., Kumar, R., & Thakar, A. (2023) · Indian Journal of Otolaryngology and Head & Neck Surgery · doi:10.1007/s12070-023-03623-6 · Cited by 2
6-Methoxydihydroavicine is a benzophenanthridine alkaloid with anti-leukemia activity
Yang, Y., & Spagnuolo, P. A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1621050 · Cited by 1
Reynolds, M. B., Hong, H. S., Michmerhuizen, B. C., Lawrence, A.-L. E., Zhang, L., Knight, J. S., Lyssiotis, C. A., Abuaita, B. H., & O’Riordan, M. X. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.07.27.501734 · Cited by 1
Reinecke, F. (2010) · Boloka Institutional Repository (North-west University)
Regulation of Mitochondrial Function by MicroRNA
Tomasetti, M., Dong, L., & Neužil, J. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_3
Epigenetic Control of Prolyl and Asparaginyl Hydroxylases in Prostate Cancer
Case, A. J. (2009) · Defense Technical Information Center (DTIC) · doi:10.21236/ada511993
Mitochondrial Complex II in Cancer
Kľučková, K., Neužil, J., & Rohlena, J. (2014) · Springer eBooks · doi:10.1007/978-94-017-8984-4_4
Transcriptional Response to Hypoxia in Developing Brain
Zhou, D. (2009) · Contemporary clinical neuroscience · doi:10.1007/978-1-60327-579-8_15
The role of EBNA binding proteins in cell transformation
Darekar, S. D. (2013) · Figshare
Mitochondrial Function in Lung Health and Disease
Puente‐Maestu, L., & Chancafe-Morgan, J. (2014) · Respiratory medicine · doi:10.1007/978-1-4939-0829-5_8
Gimenez‐Roqueplo, A. (2009) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.4.2.143
Genotype and Tumor Locus Determine Expression Profile of Pseudohypoxic Pheochromocytomas
Shankavaram, U. T., Fliedner, S. M. J., ELKAHLOUN, A. G., Barb, J. J., Munson, P. J., Huynh, T., Matro, J. C., Turková, H., Linehan, W. M., Timmers, H. J. L. M., et al. (2013)
Tumor Metabolism and Metabolomics of Pheochromocytomas and Paragangliomas
Richter, S., & Eisenhofer, G. (2016) · Springer eBooks · doi:10.1007/978-3-319-46038-3_11
Philip, B. (2014) · Griffith Research Online · doi:10.25904/1912/1367
Rusu-Moldovan, A. O., Gruia, I., Mîrza, C.-M., & Mihu, D. (2020) · Revista de Chimie · doi:10.37358/rc.20.4.8088
“Thus, it is explained why some metabolic disorders, as well as conditions associated with an inflammation threshold, express an increased amount of oxidative stress biomarkers [2, 3].”
BackgroundArasanz, H. (2020) · Academica-e (Universidad Pública de Navarra) · doi:10.48035/tesis/2454/41091
Mitochondrial metabolism and carcinogenesis
Aras, S., Purandare, N., & Grossman, L. I. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822416-8.00001-4
Beimers, W. F., Braun, M. M., Schwinefus, K., Pearson, K. S., Wilbanks, B. A., & Maher, L. J., III (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.08.467804
“An altered intracellular redox state has the potential to shift the Fe2+: Fe3+ balance required for cycles of dioxygenase activity (Guzy et al., 2008; Liu et al., 2020).”
BackgroundInfluential
Metadata
- Authors
- Guzy, R. D., Sharma, B., Bell, E., Chandel, N. S., & Schumacker, P. T.
- Affiliations
- Department of Pediatrics, Division of Neonatology
- Northwestern University (US)
- Corresponding author
- Schumacker, Paul T.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2008-01-01
- Volume
- 28
- Issue
- 2
- Pages
- 718-731
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC2223429
- OpenAlex
- W2149282639
- Semantic Scholar
- b18b26c88fdc8fd4b5c2258a52b72d9bb98605aa
- Cited by
- 427
- References
- 54
- Citations by year
- 2026: 8 · 2025: 14 · 2024: 20 · 2023: 29 · 2022: 18 · 2021: 30 · 2020: 31 · 2019: 22 · 2018: 26 · 2017: 18 · 2016: 23 · 2015: 24 · 2014: 32 · 2013: 22 · 2012: 29
- FWCI
- 7.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL 32646, HL079650, R01HL035440, R01HL079650, HL35440)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Keywords
- succinate dehydrogenase, SDHB, SDHA, reactive oxygen species, hypoxia-inducible factor alpha, HIF-1α, HIF-2α, tumor suppressor, carcinogenesis, cell proliferation
- MeSH terms
- Animals, Cell Transformation, Neoplastic, Humans, Iron-Sulfur Proteins, Male, Mice, Nude, Neoplasm Transplantation, Protein Binding, Succinate Dehydrogenase, Signal Transduction, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Protein Subunits, RNA Interference, Electron Transport Complex II, Cell Line, Tumor, Cell Proliferation, Mice, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.